Abstract
Abstract The authors did not submit an updated abstract. The original abstract should be considered final. Citation Format: Christian LaFougere, Brigitte Gueckel, Helmut Dittmann, Martina Hinterleitner, Nils Trautwein, Jonathan Cotton, Gabriele Kienzle, Stephan Singer, Gerald Reischl, Ulrich Lauer, Bernd Pichler, Lars Zender. A phase 1/2, open-label study to assess safety, tolerability, biodistribution, radiation dosimetry and PET imaging characteristics of [18F]FPyGal in comparison to in-vitro diagnostic for the assessment of senescence in oncological patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr CT178.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
